标题
Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
作者
关键词
-
出版物
Cancers
Volume 5, Issue 4, Pages 591-616
出版商
MDPI AG
发表日期
2013-05-25
DOI
10.3390/cancers5020591
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma
- (2017) German A. Marulanda et al. Cancer Control
- Methylene diphosphonate-conjugated adriamycin liposomes: preparation, characteristics, and targeted therapy for osteosarcomas in vitro and in vivo
- (2012) Daocheng Wu et al. BIOMEDICAL MICRODEVICES
- Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk
- (2012) Akira Matsunobu et al. CANCER
- Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
- (2012) D. G. Branstetter et al. CLINICAL CANCER RESEARCH
- A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma
- (2012) Florence Duffaud et al. EUROPEAN JOURNAL OF CANCER
- Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells
- (2012) Alexander G. Beristain et al. JOURNAL OF CELL SCIENCE
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- Common Musculoskeletal Tumors of Childhood and Adolescence
- (2012) Carola A.S. Arndt et al. MAYO CLINIC PROCEEDINGS
- Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
- (2012) Jean Y. Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study
- (2012) Anne B. Warwick et al. PEDIATRIC BLOOD & CANCER
- Hedgehog pathway as a drug target: Smoothened inhibitors in development
- (2012) Tara Lin et al. OncoTargets and Therapy
- Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma
- (2012) Christophe Paget et al. OncoImmunology
- A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
- (2011) G. Grignani et al. ANNALS OF ONCOLOGY
- Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma
- (2011) I. Frank Ciernik et al. CANCER
- Cell surface receptor expression patterns in osteosarcoma
- (2011) Sheref E. Hassan et al. CANCER
- Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
- (2011) Jakob K. Anninga et al. EUROPEAN JOURNAL OF CANCER
- Mifamurtide for the treatment of nonmetastatic osteosarcoma
- (2011) Kosei Ando et al. EXPERT OPINION ON PHARMACOTHERAPY
- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
- (2011) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma
- (2011) Yin-He Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process
- (2010) G. Moriceau et al. CANCER RESEARCH
- Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid Tumors
- (2010) R. Bagatell et al. CLINICAL CANCER RESEARCH
- Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group
- (2010) C. A. S. Arndt et al. CLINICAL CANCER RESEARCH
- Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome
- (2010) Irene Sulzbacher et al. PATHOLOGY
- RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma
- (2010) Jun Ah Lee et al. PEDIATRIC BLOOD & CANCER
- Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
- (2009) S. Bielack et al. ANNALS OF ONCOLOGY
- Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma
- (2009) Ayesha Abdeen et al. CANCER
- Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer
- (2009) Fu-Guo Xu et al. CANCER LETTERS
- Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo
- (2009) P. Hingorani et al. CLINICAL CANCER RESEARCH
- Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model
- (2009) A. Labrinidis et al. CLINICAL CANCER RESEARCH
- Novel therapeutic agents for osteosarcoma
- (2009) Kathleen O’Day et al. Expert Review of Anticancer Therapy
- Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
- (2009) Tudor Ciuleanu et al. LANCET
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of interferons in the treatment of osteosarcoma
- (2009) Jeremy Whelan et al. PEDIATRIC BLOOD & CANCER
- Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
- (2008) Tadahiko Kubo et al. CANCER
- Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma)
- (2008) Pete Anderson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases
- (2008) Kanji Mori et al. Expert Review of Anticancer Therapy
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
- (2008) Paul A. Meyers et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial testing of dasatinib by the pediatric preclinical testing program
- (2007) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines
- (2007) N. Bodmer et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search